Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
1
20%
Ph not_applicable
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

terminated120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Depot Naltrexone Treatment of Opioid Dependent Parolees

NCT00756990
completedphase_2

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

NCT00781898
completedphase_3

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

NCT00577408
terminatedphase_4

Pilot Study of Depot NTX in Homeless Veterans

NCT01155869
completedphase_2

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

NCT00332228

Clinical Trials (5)

Showing 5 of 5 trials
NCT00756990Not Applicable

Depot Naltrexone Treatment of Opioid Dependent Parolees

Completed
NCT00781898Phase 2

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

Completed
NCT00577408Phase 3

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

Completed
NCT01155869Phase 4

Pilot Study of Depot NTX in Homeless Veterans

Terminated
NCT00332228Phase 2

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5